Is Gastrectomy-Induced High Turnover of Bone with Hyperosteoidosis and Increase of Mineralization a Typical Osteomalacia?

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Ueyama, Takashi ^a   Yamamoto, Yuta ^a   Ueda, Kazuki ^a   Yajima, Aiji ^b,c   Maeda, Yoshimasa ^a   Yamashita, Yasunobu ^a   Ito, Takao ^a   Tsuruo, Yoshihiro ^a   Ichinose, Masao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; AGGRECAN; ALDEHYDE DEHYDROGENASE; AQUAPORIN 9; CALCITONIN; CALCITRIOL; INTERLEUKIN 1 RECEPTOR; MESSENGER RNA; OSTEOCALCIN; OSTEOCLAST DERIVED TARTRATE RESISTANT ACID PHOSPHATASE 5B; PARATHYROID HORMONE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

AGGRECAN GENE; ALDEHYDE DEHYDROGENASE 1 FAMILY MEMBER A1 GENE; ANGIOPOIETIN LIKE 4 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUAPORIN 9 GENE; ARTICLE; BODY WEIGHT; BONE DISEASE; BONE MINERALIZATION; BONE TURNOVER; CALCIUM SIGNALING; CALVARIA; CARTILAGE CELL; CONNECTIVE TISSUE; CONTROLLED STUDY; DOWN REGULATION; FEMUR; GASTRECTOMY; GENE; GENE EXPRESSION; GREMLIN 1 GENE; HYPEROSTEOIDOSIS; INTERLEUKIN 1 RECEPTOR ACCESSORY GENE; MALE; MICRO-COMPUTED TOMOGRAPHY; MICROARRAY ANALYSIS; MORPHOMETRICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOBLAST SPECIFIC FACTOR GENE; OSTEOCLAST; OSTEOMALACIA; PERIOSTIN GENE; UPREGULATION; VERY LOW DENSITY LIPOPROTEIN RECEPTOR GENE; WINGLESS TYPE MMTV INTEGRATION SITE FAMILY MEMBER 10B GENE;

ACID PHOSPHATASE; ANIMALS; BODY WEIGHT; BONE AND BONES; BONE DISEASES, METABOLIC; CALCIFICATION, PHYSIOLOGIC; CHONDROCYTES; GASTRECTOMY; ISOENZYMES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; OSTEOCALCIN; OSTEOMALACIA; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOMOGRAPHY, X-RAY COMPUTED; VITAMIN D;

MOUSE MAMMARY TUMOR VIRUS; RATTUS;

EID: 84878930344     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065685     Document Type: Article

References (45)

1. Garrick R, Ireland AW, Posen S, (1971) Bone abnormalities after gastric surgery. A prospective histlogical study. Ann Intern Med 75: 221-225.
2. Koga S, Nishimura O, Iwai N, Kishi K, Takeuchi T, et al. (1979) Clinical evaluation of long-term survival after total gastrectomy. Am J Surg 138: 635-639.
3. Editorial (1986) Osteomalacia after gastrectomy. Lancet 138: 77-78.
4. Persson P, Gagnemo-Persson R, Chen D, Axelson J, Nylander AG, et al. (1993) Gastrectomy causes bone loss in the rat: is lack of gastric acid responsible? Scand J Gastroenterol 28: 301-306.
5. Lehto-Axtelius D, Surve VV, Johnell O, Håkanson R, (2002) Effects of calcium deficiency and calcium supplementation on gastrectomy-induced osteopenia in the young male rat. Scand J Gastroenterol 37: 299-306.
6. Wojtyczka A, Bergé B, Rümenapf G, Schwille PO, Ballanti P, et al. (1998) Gastrectomy osteopenia in the rat: the role of vitamin B12 deficiency and the type of reconstruction of the digestive tract. Clin Sci (Lond) 95: 735-744.
7. Lehto-Axtelius D, Stenström M, Johnell O, (1998) Osteopenia after gastrectomy, fundectomy or antrectomy: an experimental study in the rat. Regul Pept 78: 41-50.
8. Lehto-Axtelius D, Chen D, Surve VV, Håkanson R, (2002) Post-gastrectomy osteopenia in the rat: bone structure is preserved by retaining 10%-30% of the oxyntic gland area. Scand J Gastroenterol 37: 437-443.
9. Rümenapf G, Schwille PO, Erben RG, Schreiber M, Bergé B, et al. (1998) Gastric fundectomy in the rat: effects on mineral and bone metabolism, with emphasis on the gastrin-calcitonin-parathyroid hormone-vitamin D axis. Calcif Tissue Int 63: 433-441.
10. Zellin G, Håkanson R, Linde A, (2002) Gastrectomy has no effect on bone regeneration in rats despite a decrease in bone mass. Scand J Gastroenterol 37: 1149-1155.
11. Figura N, Gennari L, Merlotti D, Lenzi C, Campagna S, et al. (2005) Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci 50: 847-852.
12. Sipponen P, Härkönen M, (2010) Hypochlorhydric stomach: a risk condition for calcium malabsorption and osteoporosis? Scand J Gastroenterol 45: 133-138.
13. Yang YX, Lewis JD, Epstein S, Metz DC, (2006) Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296: 2947-2953.
14. Eom CS, Park SM, Myung SK, Yun JM, Ahn JS, (2011) Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies. Ann Fam Med 9: 257-267.
15. Hagiwara T, Mukaisho K, Ling ZQ, Sugihara H, Hattori T, (2007) Development of pancreatic acinar cell metaplasia after successful administration of omeprazole for 6 months in rats. Dig Dis Sci 52: 1219-1224.
16. Tokudome Y, Otsuka M, Ito A, LeGeros RZ, (2009) Long-term therapeutic effect of novel calcium phosphate-based compounds injected in ovariectomized rats. J Biomed Mater Res B Appl Biomater 90: 229-237.
17. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, et al. (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610.
18. Kulak CA, Dempster DW, (2010) Bone histomorphometry: a concise review for endocrinologists and clinicians. Arq Bras Endocrinol Metabol 54: 87-98.
19. Recker RR, Kimmel DB, Dempster D, Weinstein RS, Wronski TJ, et al. (2011) Issues in modern bone histomorphometry. Bone 49: 955-964.
20. Yamamoto Y, Tanahashi T, Kawai T, Chikahisa S, Katsuura S, et al. (2009) Changes in behavior and gene expression induced by caloric restriction in C57BL/6 mice. Physiol Genomics 39: 227-235.
21. Dorsam ST, Vomhof-Dekrey E, Hermann RJ, Haring JS, Van der Steen T, et al. (2010) Identification of the early VIP-regulated transcriptome and its associated, interactome in resting and activated murine CD4 T cells. Mol Immunol 47: 1181-1194.
22. Parfitt AM (1990) Osteomalacia and related disorders, in Avioli LV, Krane SM (eds): Metabolic Bone Disease and Clinically Related Disorders. Philadelphia, PA, Saunders, 329-390.
23. Wronski TJ, Cintrón M, Doherty AL, Dann LM, (1988) Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123: 681-686.
24. Christiansen P, Steiniche T, Brockstedt H, Mosekilde L, Hessov I, et al. (1993) Primary hyperparathyroidism: iliac crest cortical thickness, structure, and remodeling evaluated by histomorphometric methods. Bone 14: 755-762.
25. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, et al. (2006) Kidney Disease: Improving Global Outcomes (KDIGO) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69: 1945-1953.
26. Malluche HH, Faugere MC, (1990) Renal bone disease 1990-an unmet challenge for the nephrologists. 38: 193-211.
27. Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänänen HK, (2006) Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab 52: 499-509.
28. Hauschka PV, Lian JB, Cole DE, Gundberg CM, (1989) Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 69: 990-1047.
29. Trouvin AP, Goëb V, (2010) Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss. Clin Interv Aging 5: 345-354.
30. Suda T, Ueno Y, Fujii K, Shinki T, (2003) Vitamin D and bone. J Cell Biochem 88: 259-266.
31. Ubara Y, Tagami T, Nakanishi S, Sawa N, Hoshino J, et al. (2005) Significance of minimodeling in dialysis patients with adynamic bone disease. Kidney Int 68: 833-839.
32. Yajima A, Inaba M, Tominaga Y, Ito A, (2007) Minimodeling reduces the rate of cortical bone loss in patients with secondary hyperparathyroidism. Am J Kidney Dis 49: 440-451.
33. Ueyama T, Shirasawa N, Numazawa M, Yamada K, Shelangouski M, et al. (2002) Gastric parietal cells: potent endocrine role in secreting estrogen as a possible regulator of gastro-hepatic axis. Endocrinology 143: 3162-3170.
34. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402(6762): 656-660.
35. Giustina A, Mazziotti G, Canalis E, (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29: 535-559.
36. Fukushima N, Hanada R, Teranishi H, Fukue Y, Tachibana T, et al. (2005) Ghrelin directly regulates bone formation. J Bone Miner Res 20: 790-798.
37. Sun Y, Ahmed S, Smith RG, (2003) Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23: 7973-7981.
38. Merle B, Garnero P, (2012) The multiple facets of periostin in bone metabolism. Osteoporos Int 23: 1199-1212.
39. Zanotti S, Smerdel-Ramoya A, Stadmeyer L, Canalis E, (2008) Activation of the ERK pathway in osteoblastic cells, role of gremlin and BMP-2. J Cell Biochem 104: 1421-1426.
40. Gentili C, Cancedda R, (2009) Cartilage and bone extracellular matrix. Curr Pharm Des 15: 1334-1348.
41. Stevens JR, Miranda-Carboni GA, Singer MA, Brugger SM, Lyons KM, et al. (2010) Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells. J Bone Miner Res 25: 2138-2147.
42. Knowles HJ, Cleton-Jansen AM, Korsching E, Athanasou NA, (2010) Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4. FASEB J 24: 4648-4659.
43. Aharon R, Bar-Shavit Z, (2006) Involvement of aquaporin 9 in osteoclast differentiation. J Biol Chem 281: 19305-19309.
44. Guarner F, Malagelada JR, (2003) Gut flora in health and disease. Lancet 361(9356): 512-519.
45. Kanno T, Matsuki T, Oka M, Utsunomiya H, Inada K, et al. (2009) Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem Biophys Res Commun 381: 666-770.